1. Home
  2. LFST vs EVO Comparison

LFST vs EVO Comparison

Compare LFST & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LifeStance Health Group Inc.

LFST

LifeStance Health Group Inc.

HOLD

Current Price

$7.08

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.16

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LFST
EVO
Founded
2015
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
1.1B
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
LFST
EVO
Price
$7.08
$3.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
1
Target Price
$8.83
$7.00
AVG Volume (30 Days)
2.4M
253.9K
Earning Date
11-06-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,367,570,000.00
$887,396,457.00
Revenue This Year
$15.75
N/A
Revenue Next Year
$14.36
$8.52
P/E Ratio
N/A
N/A
Revenue Growth
13.39
N/A
52 Week Low
$3.74
$2.84
52 Week High
$8.30
$4.80

Technical Indicators

Market Signals
Indicator
LFST
EVO
Relative Strength Index (RSI) 70.60 51.07
Support Level $6.97 $3.03
Resistance Level $7.21 $3.18
Average True Range (ATR) 0.18 0.08
MACD -0.01 0.04
Stochastic Oscillator 84.45 85.48

Price Performance

Historical Comparison
LFST
EVO

About LFST LifeStance Health Group Inc.

LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The group y has a single operating and reportable segment of mental health services.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: